leading to this feature can be distinct between this two conditions. Additionally, it appears to be more reasonable to add thrombocytopenia to clinical criteria of APS, because its frequency does not depend on SLE presence. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.1736 AB0497 SIX CASES OF MACROPHAGE ACTIVATION SYNDROME AS ,with a probability of having MAS of 96%.In all cases MAS happened simultaneously to the onset of SLE.Median age at diagnosis was 31.5 years, median SLEDAI was 12.All patients had fever above 38°C,lymphadenopathy,hematological involvement,and high titer ANA positivity. Workup for infections and malignancies was negative in all cases.All patients were treated with corticosteroids (100% received intravenous immunoglobulin pulse of methylprednisolone);concomitant medications were: cyclosporin A in 83%, IVIG in 67%, granulocyte colonystimulating factor in 17%, mycophenolate mofetil in 17%, etoposide in 17% and plasma exchange in 17%. Two patients required haemotransfusion.All cases required hospital admission, and 2 were admitted in intensive care unit. No death from MAS was observed (median follow up: 34.5 months;IQR25-48).One patient died 44 months after after MAS for pulmonary adenocarcinoma. 
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